Paula Krakowiak, Christine H Morton, Christy McCain, Dan Sun, Deepika Mathur, Alexander J Butwick, Neeru Gupta, Malini A Nijagal, Amanda Williams, Marla Seacrist, Laurence E Shields, Carolina Reyes, Miranda Klassen, Elizabeth Yznaga, Elliott K Main
{"title":"Pregnancy-Related Mortality in California Due to Obstetric Hemorrhage.","authors":"Paula Krakowiak, Christine H Morton, Christy McCain, Dan Sun, Deepika Mathur, Alexander J Butwick, Neeru Gupta, Malini A Nijagal, Amanda Williams, Marla Seacrist, Laurence E Shields, Carolina Reyes, Miranda Klassen, Elizabeth Yznaga, Elliott K Main","doi":"10.1097/AOG.0000000000005847","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To identify underlying causes, contributing factors, and quality-improvement opportunities of pregnancy-related hemorrhage deaths.</p><p><strong>Methods: </strong>The California Pregnancy-Associated Mortality Review examined pregnancy-related hemorrhage deaths in California that occurred in 2014-2018. Data were abstracted from multiple sources (vital records, hospital encounter data, medical records, and coroner or autopsy reports). A multidisciplinary expert panel reviewed all case summaries. Data from reviews were aggregated to determine underlying causes of death, preventability, contributing factors, and quality-improvement opportunities at the patient, clinician, facility, and system levels.</p><p><strong>Results: </strong>During the study period, there were 2,409,732 live births and 49 pregnancy-related hemorrhage deaths. Placenta accreta spectrum accounted for 16 (32.7%) of deaths; intra-abdominal bleeding and uterine atony each accounted for 10 deaths (20.4%). Compared with the California birth population, a significantly higher proportion of women who died were born in China (14.3% vs 3.9%); were 35 years of age or older (49.0% vs 21.9%); had two or more prior births (57.4% vs 29.1%); had cesarean deliveries (74.4% vs 31.8%); or delivered at hospitals with fewer than 1,200 births per year (33.3% vs 12.2%) (all P <.05). The committee determined that 63.3% of all hemorrhage deaths were highly preventable with substantial variation by cause. Clinician-, facility-, and system-level contributing factors were noted in 88.9% of cases and included delayed response or escalation (77.8%), delayed recognition (72.2%), and insufficient quantities of blood products used (52.8%). Corresponding quality-improvement opportunities included timely hemorrhage risk assessment; increased vigilance for identifying signs and symptoms of hemorrhage; escalation of care and aggressive management; preparation for hemorrhage complications and ongoing training for all hospitals, particularly low-resource facilities; and adherence to severe hemorrhage protocols.</p><p><strong>Conclusion: </strong>Obstetric hemorrhage remains a leading cause of pregnancy-related mortality and has multiple causes with various levels of preventability. Optimizing system-based approaches for hemorrhage preparedness, detection, and clinical management is critical to reduce preventable deaths from hemorrhage, especially among patients who do not respond to first-line treatment.</p>","PeriodicalId":19483,"journal":{"name":"Obstetrics and gynecology","volume":" ","pages":"700-709"},"PeriodicalIF":5.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics and gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/AOG.0000000000005847","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To identify underlying causes, contributing factors, and quality-improvement opportunities of pregnancy-related hemorrhage deaths.
Methods: The California Pregnancy-Associated Mortality Review examined pregnancy-related hemorrhage deaths in California that occurred in 2014-2018. Data were abstracted from multiple sources (vital records, hospital encounter data, medical records, and coroner or autopsy reports). A multidisciplinary expert panel reviewed all case summaries. Data from reviews were aggregated to determine underlying causes of death, preventability, contributing factors, and quality-improvement opportunities at the patient, clinician, facility, and system levels.
Results: During the study period, there were 2,409,732 live births and 49 pregnancy-related hemorrhage deaths. Placenta accreta spectrum accounted for 16 (32.7%) of deaths; intra-abdominal bleeding and uterine atony each accounted for 10 deaths (20.4%). Compared with the California birth population, a significantly higher proportion of women who died were born in China (14.3% vs 3.9%); were 35 years of age or older (49.0% vs 21.9%); had two or more prior births (57.4% vs 29.1%); had cesarean deliveries (74.4% vs 31.8%); or delivered at hospitals with fewer than 1,200 births per year (33.3% vs 12.2%) (all P <.05). The committee determined that 63.3% of all hemorrhage deaths were highly preventable with substantial variation by cause. Clinician-, facility-, and system-level contributing factors were noted in 88.9% of cases and included delayed response or escalation (77.8%), delayed recognition (72.2%), and insufficient quantities of blood products used (52.8%). Corresponding quality-improvement opportunities included timely hemorrhage risk assessment; increased vigilance for identifying signs and symptoms of hemorrhage; escalation of care and aggressive management; preparation for hemorrhage complications and ongoing training for all hospitals, particularly low-resource facilities; and adherence to severe hemorrhage protocols.
Conclusion: Obstetric hemorrhage remains a leading cause of pregnancy-related mortality and has multiple causes with various levels of preventability. Optimizing system-based approaches for hemorrhage preparedness, detection, and clinical management is critical to reduce preventable deaths from hemorrhage, especially among patients who do not respond to first-line treatment.
目的:确定妊娠相关出血死亡的潜在原因、影响因素和质量改善机会。方法:加州妊娠相关死亡率综述调查了2014-2018年加州发生的妊娠相关出血死亡。数据提取自多个来源(生命记录、医院就诊数据、医疗记录和验尸官或尸检报告)。一个多学科专家小组审查了所有病例摘要。汇总来自审查的数据,以确定潜在的死亡原因、可预防性、影响因素以及患者、临床医生、设施和系统层面的质量改进机会。结果:在研究期间,有2,409,732例活产和49例妊娠出血死亡。胎盘增生症16例(32.7%);腹腔出血和子宫张力失调各占10例(20.4%)。与加州出生人口相比,中国出生的女性死亡比例明显更高(14.3%对3.9%);年龄≥35岁(49.0% vs 21.9%);有两次或两次以上生育(57.4% vs 29.1%);剖宫产(74.4% vs 31.8%);或在每年少于1 200名分娩的医院分娩(33.3%对12.2%)(所有结论:产科出血仍然是妊娠相关死亡的主要原因,有多种原因,可预防程度各不相同。优化出血准备、检测和临床管理的系统方法对于减少可预防的出血死亡至关重要,特别是对一线治疗无效的患者。
期刊介绍:
"Obstetrics & Gynecology," affectionately known as "The Green Journal," is the official publication of the American College of Obstetricians and Gynecologists (ACOG). Since its inception in 1953, the journal has been dedicated to advancing the clinical practice of obstetrics and gynecology, as well as related fields. The journal's mission is to promote excellence in these areas by publishing a diverse range of articles that cover translational and clinical topics.
"Obstetrics & Gynecology" provides a platform for the dissemination of evidence-based research, clinical guidelines, and expert opinions that are essential for the continuous improvement of women's health care. The journal's content is designed to inform and educate obstetricians, gynecologists, and other healthcare professionals, ensuring that they stay abreast of the latest developments and best practices in their field.